African Union to receive 220 million doses of Janssen COVID-19 Vaccine
The African Vaccine Acquisition Trust (AVAT) has entered into an advanced purchase agreement for 220 million doses of Janssen COVID-19 Vaccine.
List view / Grid view
The African Vaccine Acquisition Trust (AVAT) has entered into an advanced purchase agreement for 220 million doses of Janssen COVID-19 Vaccine.
Developed by Janssen, the two-dose regimen has already been given to 60,000 patients and now has the positive opinion of the Committee for Medicinal Products for Human Use (CHMP).
2 December 2015 | By Victoria White
Johnson & Johnson has announced four new public-private partnerships to significantly reduce the burden of HIV incidence, especially among adolescent girls...
11 November 2014 | By Janssen
Compared with their peers and other caregivers, carers for adults with schizophrenia report deteriorated physical and mental health and greater health resource usage/utilisation...
7 October 2013 | By Mengele PMC
Lab will allow development of even more powerful supercomputers for life sciences research...
7 October 2013 | By Publicis Life Brands Resolute
New report presents unique statistics on health R&D in the European Union...
14 May 2012 | By University of Dundee
The consortium includes six companies & will provide core support of £14.4 million...
14 March 2011 | By Janssen Pharmaceutica NV
Janssen Pharmaceutica NV has received an offer from Elanco to acquire its Janssen Animal Health business...
3 March 2011 | By The Scott Partnership
PRECOS will be discussing in vitro and in vivo modeling of the human TME...
1 December 2010 | By Johnson & Johnson
Janssen announced a research agreement to collaborate with GE Healthcare...
22 November 2010 | By The Scott Partnership
PRECOS, has signed a significant service agreement with a leading global pharmaceutical company Janssen Pharmaceutica N.V...